6Khabir A, Sellami A, Sakka M, et al. Contrasted Frequencies of p53 accumulation in the two age group of north African nasopharyngeal carcinomas. Clinical Cancer Research, 2000 6(10): 3932-3936
7Shi W, Pataki I, MacMillan C, et al. Molecular pathology parameters in human nasopharyngeal carcinoma. Cancer, 2002, 94(7): 1997 -2006
8Weinrib L, Li J H, Donovan J, et al. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma. Cancer Gene Therapy, 2001, 8 (5):352 - 360
9Momand J, Zambetti G P, Olson D C, et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 1992, 69 (7): 1237 - 1245
10Selkirk J K, Merrick B A, Stackhouse B L, et al. Multiple p53protein isoforms and formation of oligomeric complexes with heat shock proteins Hsp70 and Hsp90 in the human mammary tumor,T47D, cell line. Appl Theor Electrophor, 1994, 4 ( 1 ): 11 ～ 18
